Pharmaceutical representative licensing

During the 2021 Oregon Legislative Session, Senate Bill 763 was enacted. This bill provides that a person may not engage in business as pharmaceutical representative in Oregon without obtaining a license from the director of DCBS, unless the pharmaceutical representative engages in business for fewer than 15 days during the calendar year.

Permanent Rules for Pharmaceutical Sales Representative Licensing.

Starting January 1st, 2022, a Pharmaceutical Sales Representative license is required for those that meet the requirements for this license. Applicants for a Pharmaceutical Sales Representative license may complete an online application or renewal at NIPR.com.

For Applicants:

1. In order to satisfy the prelicensure education requirement for an initial pharmaceutical representative license, applicants must complete a course(s) of at least 10 hours and 5 hours continuing education prior for a renewal license. For initial applications taken prior to July 2022, licenses will be approved conditional on the completion of pre-licensing prior to renewal for 2023. Applications after July 2022 will need to complete the required education prior to applying for the license. Education program directions and classes will be posted on this page in mid-2022. 
2. A disclosure log must be maintained by license holders that documents their interactions with health care providers. The log for 2022 must be turned in to the program by April 1st, 2023. This reporting spreadsheet is available on this webpage.

Contacts

Kevin Kemper
Pharmaceutical Sales Representative Licensing Technician
DFR.PharmaSalesRep@dcbs.oregon.gov

Tina Boone
Educational Coordinator
Christina.M.Boone@dcbs.oregon.gov

Additional resources

• NIPR.com
• State Based Systems for Organizations
• Senate Bill 763
  

Video tutorial

• Step-by-step directions 
• Education provider instructions 
• Frequently asked questions (FAQs)